Sichuan Zitonggong Pharmaceutical

Sichuan Zitonggong Pharmaceutical is a high-tech pharmaceutical company based in Neijiang, Sichuan, China, specializing in the R&D, production, and marketing of chemical drugs and Traditional Chinese Medicines (TCM). Founded in 2005, the company carries the Zitonggong brand, which is recognized as a China Time-honored Brand with a history dating back to 1780. Zitonggong is listed on the Beijing Stock Exchange (832566) and maintains a diverse portfolio of marketed products, including Rizatriptan Benzoate for migraines and Celecoxib for arthritis. The company is actively advancing its pipeline with innovative projects like the Phase 1 anti-cancer candidate Majiazi Capsule and several improved generic formulations in pain management and gynecology. With multiple GMP-certified production bases, Zitonggong is a key player in the Chinese neurology, gastroenterology, and pain treatment markets.